IDENTIFICATION AND PREDICTION OF T-CELL EPITOPES BY USING HLA CLASS II-BINDING PEPTIDE MOTIFS

使用 HLA II 类结合肽基序识别和预测 T 细胞表位

基本信息

  • 批准号:
    06454222
  • 负责人:
  • 金额:
    $ 4.54万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1994
  • 资助国家:
    日本
  • 起止时间:
    1994 至 1996
  • 项目状态:
    已结题

项目摘要

Recent advances in knowledge of crystal structures of MHC class II molecules has advanced understanding of the molecular basis for interactions between peptides and HLA class II molecules. Polymorphism of HLA class II molecules influences structures of peptides bound to HLA class II molecules. To elucidate mechanisms for statistical association between particular HLA class II alleles and susceptibility to autoimmune diseases, it is important to identify self peptides presented by disease-susceptible HLA class II molecules and triggering disease-causative autoreactive T cells. In this study, we tryed to identify self-peptides triggering autoimmune diseases including rheumatoid arthritis, insulin autoimmune syndrome, insulin dependent diabetes mellitus and infant-onset myasthenia gravis. Susceptibility to all of these diseases in the Japanese population are known to be strongly associated with particular HLA-DR-DQ haplotypes unique to Asians, and clinical features of some of these diseas … More es are different between Caucasians and Asians including Japanese. We investigated differences in binding-peptide motifs between disease susceptible and non-susceptible HLA class II molecules and predicted candidates of autoimmune self-peptides carrying binding-motifs to disease-susceptible HLA class II molecules. Indeed the major epitope for insulin-autoreactive CD4^+T cell was successfully identified by this strategy. We also found heterogeneity in immunogenetic background between Western type and Asian type of multiple sclerosis. Our data indicated that our strategy is useful to identify autoimmune self-peptides, and it is suggested that not only disease-susceptible HLA class II but also self-peptides causing diseases are different between Caucasians and Asians. These differences may well correlate to different clinical manifestations of diseases between the two ethnic groups. Recently it was found that T cell respose to antigen was not an on/off phenomenon, and altered T cell responses to altered peptide ligands were reported in mouse. We investigated responses of human T cell clones specific to non-self peptides to large panels of analogue peptides to find frequent alterations of T cell responses. This basic knowledg of altered human T cell responses may be useful for manipulation by altered peptide ligands of human pathogenic autoreactive T cell responses. Less
MHC II类分子的晶体结构的知识的最新进展已经推进了对肽和HLA II类分子之间相互作用的分子基础的理解。HLA II类分子的多态性影响与HLA II类分子结合的肽的结构。为了阐明特定HLA II类等位基因与自身免疫性疾病易感性之间的统计学关联机制,重要的是鉴定由疾病易感的HLA II类分子呈递并触发致病性自身反应性T细胞的自身肽。在本研究中,我们试图找出触发自身免疫性疾病,包括类风湿性关节炎,胰岛素自身免疫综合征,胰岛素依赖型糖尿病和婴儿型重症肌无力的自身肽。已知日本人群对所有这些疾病的易感性与亚洲人特有的特定HLA-DR-DQ单倍型以及其中一些疾病的临床特征密切相关。 ...更多信息 高加索人和亚洲人包括日本人的情况不同。我们研究了疾病易感和非易感HLA II类分子之间结合肽基序的差异,并预测了携带疾病易感HLA II类分子结合基序的自身免疫自身肽的候选者。事实上,通过这种策略成功地鉴定了胰岛素自身反应性CD 4 ^+T细胞的主要表位。我们还发现西方型和亚洲型多发性硬化症之间的免疫遗传背景的异质性。我们的数据表明,我们的策略是有用的,以确定自身免疫性自身肽,这表明,不仅疾病易感的HLA II类,但也引起疾病的自身肽是不同的高加索人和亚洲人之间。这些差异很可能与两个民族之间疾病的不同临床表现有关。最近发现T细胞对抗原的反应不是一个开/关现象,并且在小鼠中报道了T细胞对改变的肽配体的反应改变。我们研究了对非自身肽特异性的人T细胞克隆对大量类似肽的反应,以发现T细胞反应的频繁改变。这种改变的人T细胞应答的基本知识可能有助于通过改变的人致病性自身反应性T细胞应答的肽配体进行操纵。少

项目成果

期刊论文数量(200)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Matsuoka,M.et al.: "ATL cells recognize self class II HLA antigens : implication to leukemogenesis." Leukemia. 9. 1338-1343 (1995)
Matsuoka,M.et al.:“ATL 细胞识别自身 II 类 HLA 抗原:对白血病发生的影响。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Murakami,S.et al.: "Binding of Ras- or p53-derived peptides to HLA-DR molecules : possible candidates of targets for tumor specific T Lymphocytes" Immunol.Letters. 49. 149-153 (1996)
Murakami,S.et al.:“Ras 或 p53 衍生肽与 HLA-DR 分子的结合:肿瘤特异性 T 淋巴细胞靶标的可能候选者”Immunol.Letters。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Matsushita,S.et al.: "HLA-DQ-binding peptide motifs.I.Comparative binding analysis of type II collage-derived peptides to DR an DQ molecules of rheumatoid arthritis-susceptible haplotypes" Int.Immunol.8. 757-764 (1996)
Matsushita,S.et al.:“HLA-DQ 结合肽基序。I.II 型胶原衍生肽与类风湿性关节炎易感单倍型的 DR 和 DQ 分子的比较结合分析”Int.Immunol.8。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Fujisao,S.et: "Evaluation of peptide-HLA-binding by an enzyme-linked assay and its application to the detailed peptide motifs for HLA-DR9 (DRB1^*0901)." J.Immunol.Methods.(in press).
Fujisao,S.et:“通过酶联测定评估肽-HLA 结合及其在 HLA-DR9 (DRB1^*0901) 详细肽基序中的应用。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Senju,S.,et al.: "Identification of human and mouse GP-1,members of a novel G-protein family." Biochem.Biophys.Res.Comm.(in press).
Senju,S.,et al.:“人类和小鼠 GP-1 的鉴定,它是一种新型 G 蛋白家族的成员。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NISHIMURA Yasuharu其他文献

NISHIMURA Yasuharu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NISHIMURA Yasuharu', 18)}}的其他基金

Development of new cancer immunotherapy aiming activation of both anti-tumor killer and helper T cells
开发新的癌症免疫疗法,旨在激活抗肿瘤杀伤细胞和辅助 T 细胞
  • 批准号:
    24300334
  • 财政年份:
    2012
  • 资助金额:
    $ 4.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of cellular cancer immunotherapy by using humaniPS-cell-derived dendritic cells and ideal cancer-associated antigens
利用人PS细胞衍生的树突状细胞和理想的癌症相关抗原开发细胞癌症免疫疗法
  • 批准号:
    23650609
  • 财政年份:
    2011
  • 资助金额:
    $ 4.54万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Investigation on the molecular mechanisms of antigen presentation and recognition.
抗原呈递和识别的分子机制研究。
  • 批准号:
    14370115
  • 财政年份:
    2002
  • 资助金额:
    $ 4.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Identification of tumor-specific antigens recognized by human T cells
人类 T 细胞识别的肿瘤特异性抗原的鉴定
  • 批准号:
    12213111
  • 财政年份:
    2000
  • 资助金额:
    $ 4.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
THE DIVESITY IN ANTIGEN RECOGNITION AND RESPONSE OF ANTIGEN-SPECIFIC HUMAN CD4^+ T-CELL CLONES
抗原特异性人类 CD4^ T 细胞克隆的抗原识别和反应的多样性
  • 批准号:
    11557027
  • 财政年份:
    1999
  • 资助金额:
    $ 4.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of TCR/HLA/ peptide interaction and investigation of etiology of autoimmune diseases
TCR/HLA/肽相互作用分析及自身免疫性疾病病因学研究
  • 批准号:
    11694294
  • 财政年份:
    1999
  • 资助金额:
    $ 4.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
ANALYSIS OF AUTOANTIGENIC PEPTIDE-HLA CLASS II COMPLEXES ASSOCIATED WITH AUTOIMMUNE DISEASES
与自身免疫性疾病相关的自身抗原肽-HLA II 类复合物的分析
  • 批准号:
    09470097
  • 财政年份:
    1997
  • 资助金额:
    $ 4.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
An approach to generate a library of CHO cells expressing diverse HLA class II plus peptide complexes for identification of TCR-ligands by using CLIP-substituted invariant chains
一种生成表达多种 HLA II 类加肽复合物的 CHO 细胞文库的方法,用于通过使用 CLIP 取代的不变链鉴定 TCR 配体
  • 批准号:
    08557027
  • 财政年份:
    1996
  • 资助金额:
    $ 4.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Effects of polymorphism of HLA on binding of antigenic peptides to HLA and recognition of peptides complexed with HLA by T cell receptor
HLA多态性对抗原肽与HLA结合及T细胞受体识别HLA复合肽的影响
  • 批准号:
    03452276
  • 财政年份:
    1991
  • 资助金额:
    $ 4.54万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Production of monoclonal antibody specific to HLA by utilizing HLA transgenic mice.
利用 HLA 转基因小鼠生产 HLA 特异性单克隆抗体。
  • 批准号:
    01870026
  • 财政年份:
    1989
  • 资助金额:
    $ 4.54万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research

相似国自然基金

Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
  • 批准号:
    31171277
  • 批准年份:
    2011
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目

相似海外基金

Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
  • 批准号:
    479128
  • 财政年份:
    2023
  • 资助金额:
    $ 4.54万
  • 项目类别:
    Operating Grants
Effects of maternal immune activation on autoimmune diseases in offsprings
母体免疫激活对后代自身免疫性疾病的影响
  • 批准号:
    23H02155
  • 财政年份:
    2023
  • 资助金额:
    $ 4.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC)
IPP:自身免疫性疾病统计和临床协调中心 (ADSCCC)
  • 批准号:
    10788032
  • 财政年份:
    2023
  • 资助金额:
    $ 4.54万
  • 项目类别:
Biomarkers of vascular endothelial dysfunction in systemic autoimmune diseases: analysis of circulating microRNAs
系统性自身免疫性疾病中血管内皮功能障碍的生物标志物:循环 microRNA 分析
  • 批准号:
    23K14742
  • 财政年份:
    2023
  • 资助金额:
    $ 4.54万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Structural mechanisms of autoimmune diseases targeting cys-loop receptors
针对半胱氨酸环受体的自身免疫性疾病的结构机制
  • 批准号:
    10864719
  • 财政年份:
    2023
  • 资助金额:
    $ 4.54万
  • 项目类别:
Developing non-immunosuppressive immune-based therapeutics for targeted treatment of autoimmune diseases
开发非免疫抑制性免疫疗法来靶向治疗自身免疫性疾病
  • 批准号:
    10586562
  • 财政年份:
    2023
  • 资助金额:
    $ 4.54万
  • 项目类别:
NOVEL HUMORAL AND CELLULAR BIOMARKERS OF AUTOIMMUNE DISEASES CAUSED BY IMMUNOTHERAPY
免疫治疗引起的自身免疫性疾病的新型体液和细胞生物标志物
  • 批准号:
    10593224
  • 财政年份:
    2023
  • 资助金额:
    $ 4.54万
  • 项目类别:
Regulation of autoimmune diseases by PTPN22 phosphatase
PTPN22磷酸酶对自身免疫性疾病的调节
  • 批准号:
    23K06589
  • 财政年份:
    2023
  • 资助金额:
    $ 4.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Decipher and target GABA metabolism and GABA receptor-mediated signaling in autoimmune diseases
破译并靶向自身免疫性疾病中的 GABA 代谢和 GABA 受体介导的信号传导
  • 批准号:
    10623380
  • 财政年份:
    2023
  • 资助金额:
    $ 4.54万
  • 项目类别:
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies
靶向催乳素受体的长亚型来治疗自身免疫性疾病和 B 细胞恶性肿瘤
  • 批准号:
    10735148
  • 财政年份:
    2023
  • 资助金额:
    $ 4.54万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了